Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects

PURPOSE: A new fixed-dose combination (FDC) formulation of 120 mg fimasartan and 20 mg rosuvastatin was developed to increase therapeutic convenience and improve treatment compliance. METHODS: A randomized, open-label, single-dose, two-treatment, two-way crossover study with a 7-day washout period w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Woo Youl, Seong, Sook Jin, Ohk, Boram, Gwon, Mi-Ri, Kim, Bo Kyung, Cho, Seungil, Shim, Wang-Seob, Lee, Kyung-Tae, Kim, Eun Hee, Yang, Dong Heon, Lee, Hae Won, Yoon, Young-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208487/
https://www.ncbi.nlm.nih.gov/pubmed/30464392
http://dx.doi.org/10.2147/DDDT.S161917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208487/
https://www.ncbi.nlm.nih.gov/pubmed/30464392
http://dx.doi.org/10.2147/DDDT.S161917

Ejemplares similares